DK1888537T3 - Fremgangsmåde til fremstilling af 4[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino]benzonitril - Google Patents

Fremgangsmåde til fremstilling af 4[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino]benzonitril

Info

Publication number
DK1888537T3
DK1888537T3 DK06755299.2T DK06755299T DK1888537T3 DK 1888537 T3 DK1888537 T3 DK 1888537T3 DK 06755299 T DK06755299 T DK 06755299T DK 1888537 T3 DK1888537 T3 DK 1888537T3
Authority
DK
Denmark
Prior art keywords
dihydro
oxo
benzonitrile
pyrimidinyl
amino
Prior art date
Application number
DK06755299.2T
Other languages
Danish (da)
English (en)
Inventor
Didier Philippe Robert Schils
Alfred Elisabeth Stappers
Original Assignee
Janssen R & D Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35822492&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1888537(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen R & D Ireland filed Critical Janssen R & D Ireland
Application granted granted Critical
Publication of DK1888537T3 publication Critical patent/DK1888537T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK06755299.2T 2005-05-26 2006-05-24 Fremgangsmåde til fremstilling af 4[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino]benzonitril DK1888537T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05104531 2005-05-26
US68599305P 2005-05-31 2005-05-31
PCT/EP2006/062606 WO2006125809A1 (en) 2005-05-26 2006-05-24 Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile

Publications (1)

Publication Number Publication Date
DK1888537T3 true DK1888537T3 (da) 2013-12-09

Family

ID=35822492

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06755299.2T DK1888537T3 (da) 2005-05-26 2006-05-24 Fremgangsmåde til fremstilling af 4[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino]benzonitril

Country Status (19)

Country Link
US (2) US8101752B2 (https=)
EP (1) EP1888537B1 (https=)
JP (2) JP5148483B2 (https=)
CN (1) CN101248051B (https=)
AU (1) AU2006251163C1 (https=)
BR (1) BRPI0611038B8 (https=)
CA (1) CA2609716C (https=)
DK (1) DK1888537T3 (https=)
ES (1) ES2437202T3 (https=)
HR (1) HRP20131133T1 (https=)
IN (1) IN2014DN04588A (https=)
ME (1) ME01612B (https=)
MX (1) MX2007014881A (https=)
PL (1) PL1888537T3 (https=)
PT (1) PT1888537E (https=)
RS (1) RS53062B (https=)
RU (1) RU2458056C2 (https=)
SI (1) SI1888537T1 (https=)
WO (1) WO2006125809A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006251163C1 (en) * 2005-05-26 2012-07-12 Janssen Sciences Ireland Uc Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile
WO2012125993A1 (en) 2011-03-17 2012-09-20 Teva Pharmaceutical Industries Ltd. Solid state forms of rilpivirine base, and rilipivirine salts
MX351340B (es) 2012-03-13 2017-10-11 Octapharma Ag Proceso mejorado para la produccion de fibrinogeno y fibrinogeno producido por este.
CN103058936B (zh) * 2013-01-23 2016-01-06 宁波九胜创新医药科技有限公司 4-[(4-氯-2-嘧啶基)氨基]苯腈的制备方法
CN103193719B (zh) * 2013-04-08 2015-07-22 宁波九胜创新医药科技有限公司 一种4-[(4-羟基-2-嘧啶基)氨基]苯腈的制备方法
CN114933567B (zh) * 2022-04-29 2023-07-11 武汉工程大学 一种2-甲硫基-4-嘧啶酮的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63502B1 (en) 1989-04-21 1995-05-03 Zeneca Ltd Aminopyrimidine derivatives useful for treating cardiovascular disorders
DE3923979A1 (de) 1989-07-20 1991-01-24 Merck Patent Gmbh Verfahren zur herstellung von aromatischen nitrilen
RU2037483C1 (ru) * 1989-07-20 1995-06-19 Мерк Патент Гмбх Способ получения замещенных ароматических нитрилов
CZ299380B6 (cs) * 1998-03-27 2008-07-09 Janssen Pharmaceutica N. V. Pyrimidinová sloucenina, použití této slouceniny pro prípravu léciva, farmaceutický prostredek tutoslouceninu obsahující, zpusob prípravy tohoto prostredku a uvedené slouceniny a kombinace a produktuvedenou slouceninu obsahující
HRP20080359B1 (hr) * 1998-11-10 2016-01-01 Janssen Pharmaceutica N.V. PIRIMIDINI KOJI INHIBIRAJU REPLIKACIJU HIV-a
CA2384188C (en) * 1999-09-24 2008-06-17 Janssen Pharmaceutica N.V. Antiviral compositions
JP4969010B2 (ja) * 2000-05-08 2012-07-04 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Hiv複製阻害性ピリミジンのプロドラッグ
JO3429B1 (ar) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
MXPA04004178A (es) * 2001-11-01 2004-09-06 Janssen Pharmaceutica Nv Heteroarilaminas como inhibidores de glucogeno cintasa cinasa 3beta.
KR101140785B1 (ko) * 2002-08-09 2012-05-03 얀센 파마슈티카 엔.브이. 4-〔〔4-〔〔4-(2-시아노에테닐)-2,6-디메틸페닐〕아미노〕-2-피리미디닐〕아미노〕벤조니트릴의 제조방법
EP1673348B1 (en) * 2003-09-30 2009-04-01 Janssen Pharmaceutica N.V. Benzoimidazole compounds
AU2006251163C1 (en) * 2005-05-26 2012-07-12 Janssen Sciences Ireland Uc Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile

Also Published As

Publication number Publication date
US8101752B2 (en) 2012-01-24
CN101248051B (zh) 2013-07-17
PT1888537E (pt) 2013-11-26
ES2437202T3 (es) 2014-01-09
BRPI0611038A2 (pt) 2010-08-10
CA2609716C (en) 2014-10-14
JP2008545680A (ja) 2008-12-18
CN101248051A (zh) 2008-08-20
CA2609716A1 (en) 2006-11-30
AU2006251163A1 (en) 2006-11-30
EP1888537A1 (en) 2008-02-20
RU2458056C2 (ru) 2012-08-10
RU2007148968A (ru) 2009-07-10
HK1123551A1 (en) 2009-06-19
JP2013040194A (ja) 2013-02-28
BRPI0611038B8 (pt) 2022-10-25
BRPI0611038B1 (pt) 2022-02-08
WO2006125809A1 (en) 2006-11-30
US8618291B2 (en) 2013-12-31
ME01612B (me) 2014-09-20
PL1888537T3 (pl) 2014-02-28
AU2006251163B2 (en) 2012-03-08
US20120083606A1 (en) 2012-04-05
RS53062B (sr) 2014-04-30
US20080171878A1 (en) 2008-07-17
AU2006251163C1 (en) 2012-07-12
EP1888537B1 (en) 2013-09-11
JP5148483B2 (ja) 2013-02-20
IN2014DN04588A (https=) 2015-07-10
SI1888537T1 (sl) 2014-01-31
JP5580385B2 (ja) 2014-08-27
HRP20131133T1 (hr) 2014-01-03
MX2007014881A (es) 2008-02-15

Similar Documents

Publication Publication Date Title
NO20063780L (no) Fremgangsmate for fremstilling av 2-aminitiazol-5-aromatisk karboksamid som kinase inhibitorer.
IN2014CN02050A (https=)
DK1881957T3 (da) Fremgangsmåde til fremstilling af biproduktfattige methylglycin-N,N-diedikkesyre-trialkalimetalsalte
NO20082749L (no) Fremgangsmate for fremstilling av ferri-succinylkasein
DK1951747T3 (da) Fremgangsmåde og mellemprodukter til syntese af caspofungin
NO20081617L (no) Metoder for fremstilling av Glutaminsyrederivater
TW200640912A (en) Novel processes for the preparation of a 2H-chromene
DK1888537T3 (da) Fremgangsmåde til fremstilling af 4[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino]benzonitril
SI1747190T1 (sl) Postopek za pripravo valsartana in njegovih prekurzorjev
NO20075829L (no) Syntese
TW200633977A (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
TW200719889A (en) Amino acid derivatives
DK1877370T3 (da) Fremgangsmåde til fremstilling af hydrazon-derivater
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
DE602006005230D1 (de) Verfahren zur herstellung von 2-azabicycloä3.3.0üoctan-3-carbonsäurederivaten
DE502005004039D1 (de) Verfahren zur herstellung hochmolekularer polyamide
DK1819704T3 (da) Pyrrolopyridin-2-carboxylsyre-amid-derivat anvendelig som inhibitor af glycogenphosphorylase
DE602004008486D1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-ä2-amino-6-chlor-9h-purin-9-ylü-2-cyclopenten-1-methanol
DE502006003346D1 (de) Verfahren zur herstellung von beta-aminopropionsäurederivaten
CY1114812T1 (el) Διεργασια για την παρασκευη 4-[(1,6-διυδρο-6-οξο-2-πυριμιδινυλ)-αμινο]βενζονιτριλιου
DK1919856T3 (da) Fremgangsmåde til fremstilling af gabapentin
DE602007007773D1 (de) Verfahren zur synthese von ibandronat-natrium
DK1902033T3 (da) Fremgangsmåde til fremstilling af caboxamider
ITMI20040582A1 (it) Processo per la semisintesi di deserpidina
WO2009109866A3 (en) Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-n-[4-methyl-3- (4-pyridin-3-yl-pyrimidin-2ylamino)-phenyl]-benzamide